Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Bactiguard Holding AB (publ) is a Sweden-based medTech company specializing in infection prevention technology to combat device-related healthcare-associated infections. Its core innovation, Bactiguard Infection Protection, features an ultra-thin noble metal coating of gold, palladium, and silver that permanently binds to medical device surfaces, preventing bacterial adhesion and biofilm formation. The company targets high-need therapeutic areas including orthopedics, cardiology, neurology, urology, and vascular access, with products like BIP Foley Catheters, Endotracheal Tubes, Central Venous Catheters, and orthopedic trauma implants. Bactiguard operates primarily through license partnerships with global leaders such as Becton Dickinson, Zimmer Biomet, and Well Lead Medical, enabling widespread application of its technology under partner brands. It also offers a wound management portfolio, including the Hydrocyn aqua antimicrobial solutions and surgical sutures, supporting improved healing and infection control. Headquartered in Stockholm and founded in 2005, Bactiguard plays a vital role in reducing patient suffering, alleviating healthcare burdens, and addressing antimicrobial resistance through biocompatible innovations.